Apollon Wealth Management, LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1764387 MOUNT PLEASANT, SC

Back to TEVA Full portfolio

Position in TEVA

as of Mar 31, 2026 · filed Apr 22, 2026 Compact

Position Value

$247,767

-$28,256 QoQ

Shares Held

8,226

-68.9% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Apollon Wealth Management, LLC holds $10,905,872 across 10 Drug Manufacturers - Specialty & Generic names. TEVA ranks #4 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	13,288	$7,879,518
2	ZTS	Zoetis Inc.	15,247	$1,802,347
3	VTRS	Viatris Inc	21,628	$292,194
4	TEVA	Teva Pharmaceutical Industries Ltd This page	8,226	$247,767
5	LQDA	Liquidia Corp	6,535	$246,630
6	HLN	Haleon plc	21,271	$212,922
7	TLRY	Tilray Brands, Inc.	14,761	$95,503
8	CRON	Cronos Group Inc.	21,924	$55,029

All Filings in TEVA

Export CSV

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$247,767	8,226	-68.9%	Shares	Sole	2026-04-22
2023-12-31	$276,023	26,439	+0.2%	Shares	Sole	2024-02-06
2023-09-30	$269,065	26,379	-12.2%	Shares	Sole	2023-11-14
2023-06-30	$226,110	30,028	-0.9%	Shares	Sole	2023-08-04
2023-03-31	$268,270	30,313	+28.3%	Shares	Sole	2023-05-16
2022-12-31	$215,487	23,628	-1.0%	Shares	Sole	2023-02-15
2022-09-30	$192,574	23,863	-0.8%	Shares	Sole	2022-11-08
2022-06-30	$180,953	24,063	+20.7%	Shares	Sole	2022-08-11
2022-03-31	$187,217	19,938	-7.4%	Shares	Sole	2022-05-16
2021-12-31	$172,519	21,538	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.